Skip to content

Checked

Class IIDrug recallTerminated

Atropine sulfate 0.05% recall

Recalled by Pharmacy Innovations of Erie, PA · FDA report 02/01/2023

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Terminated
Closed 07/31/2024
Recall started
12/22/2022
Distribution
Nationwide

Reason for recall

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Atropine sulfate 0.05%, 1ML dropper, and Atropine sulfate 0.01%, 1 ML dropper, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Lot and code info
t20221025@32 t20221025@33
Recall number
D-0194-2023
Event ID
91332
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA

  • Nationwide

Recall timeline

  1. 12/22/2022Firm started the recall
  2. 01/26/2023FDA classified it as Class II
  3. 02/01/2023Published in the FDA enforcement report
  4. 07/31/2024FDA closed (terminated) the recall

All products in this recall

59 products under event 91332

Frequently asked questions

Why was Atropine sulfate 0.05% recalled?
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide in the USA
Is this recall still active?
The FDA lists the recall as terminated (closed 07/31/2024). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 02/01/2023 · Do not rely on openFDA to make decisions regarding medical care